Neglecting to screen women between 40 and 49 years old with mammography: What is the impact on treatment morbidity and potential risk reduction?

American Journal of Roentgenology

Volumn 202, Issue 2, 2014, Pages 282-288

  Plecha, Donna ^a   Salem, Nelly ^a   Kremer, Mallory ^b   Pham, Ramya ^a   Downs Holmes, Catherine ^a   Sattar, Abdus ^c   Lyons, Janice ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Guidelines; Screening mammogram; U.S. Preventive Services Task Force

Indexed keywords

ADULT; AXILLARY LYMPH NODE; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; COMPARATIVE STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MORBIDITY; NEGLECT; NOTE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADULT; AGE FACTORS; BIOPSY, NEEDLE; BREAST NEOPLASMS; DECISION MAKING; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84892766449     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.11382     Document Type: Note

References (33)

1. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151:727-737; W237-W742
2. Duffy SW, Tabár L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002; 95:458-469
3. Hendrick RE, Smith RA, Rutledge JH 3rd, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997; 22:87-92
4. Jonsson H, Bordas P, Wallin H, Nystrom L, Lenner P. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update. J Med Screen 2007; 14:87-93
5. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003; 361:1411-1417
6. Tabár L, Gad A, Holmberg LH, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 325:829-832
7. Tabár L, Gad A, Holmberg LH, Ljungquist U. Significant reduction in advanced breast cancer: results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med 1985; 54:158-164
8. Tabár L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001; 91:1724-1731
9. Tabár L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003; 361:1405-1410
10. Davidson AS, Liao X, Magee BD. Attitudes of women in their forties toward the 2009 USPSTF mammogram guidelines: a randomized trial on the effects of media exposure. Am J Obstet Gynecol 2011; 205:30.e31-30.e37
11. Wang A, van Houten H, Fan J, Shah ND. Impact of the United States Preventive Services Task Force Update for Breast Cancer Screening on utilization of mammography in women under 50. (abstract) In: Academy Health Annual Research Meeting. Orlando, FL: Academy Health, 2012. Academy Health website. www.academyhealth.org/files/ARM/Poster%20Presentation%20Abstracts%20updated%206- 21.pdf. Accessed October 16, 2013
12. Takahashi J, Hardesty L, Jin M, Horn W. Survey of screening mammography ordering practices of primary care physicians before and after the release of the November 2009 United States Preventive Services Task Force Screening Mammography Guidelines. In: ARRS Annual Meeting, Chicago, IL: American Roentgen Ray Society, 2011. ARRS website. www.arrs.org/uploadedFiles/ARRS/Education/ Meetings/AN11/ARRS-program-bk-2011. pdf. Accessed October 16, 2013
13. Kremer ME, Downs-Holmes C, Novak RD, et al. Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis? AJR 2012; 198:1218-1222
14. Onitilo AA, Engel JM, Liang H, et al. Mammography utilization: patient characteristics and breast cancer stage at diagnosis. AJR 2013 [Epub ahead of print]
15. Gloekler Ries LA, Eisner MP. Chapter 13: cancer of the female breast. Surveillance Epidemiology and End Results survival monograph: cancer survival among adults. National Cancer Institute website. seer.cancer.gov/publications/ survival/surv-breast.pdf. Accessed September 30, 2013
16. Coldman A, Phillips N, Warren L, Kan L. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer 2007; 120:1076-1080
17. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 2011; 117:714-722
18. Webb ML, Cady B, Michaelson JS, et al. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer 2013 [Epub ahead of print]
19. Barth RJ Jr, Gibson GR, Carney PA, Mott LA, Becher RD, Poplack SP. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy. AJR 2005; 184:324-329
20. Maibenco D, Daoud Y, Phillips E, Saxe A. Relationship between method of detection of breast cancer and stage of disease, method of treatment, and survival in women aged 40 to 49 years. Am Surg 1999; 65:1061-1066
21. Mook S, Van 't Veer LJ, Rutgers EJ, et al. Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst 2011; 103:585-597
22. Nagtegaal ID, Allgood PC, Duffy SW, et al. Prognosis and pathology of screen-detected carcinomas: how different are they? Cancer 2011; 117:1360-1368
23. Spillane AJ, Kennedy CW, Gillett DJ, et al. Screen-detected breast cancer compared to symptomatic presentation: an analysis of surgical treatment and end-points of effective mammographic screening. ANZ J Surg 2001; 71:398-402
24. Coldman AJ, Phillips N, Speers C. A retrospective study of the effect of participation in screening mammography on the use of chemotherapy and breast conserving surgery. Int J Cancer 2007; 120:2185-2190
25. Malmgren JA, Parikh J, Atwood MK, Kaplan HG. Impact of mammography detection on the course of breast cancer in women aged 40-49 years. Radiology 2012; 262:797-806
26. Coopey SB, Mazzola E, Buckley JM, et al. The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat 2012; 136:627-633
27. Cuzick J, Powles T, Veronesi U, et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003; 361:296-300
28. Chuba PJ, Hamre MR, Yap J, et al. Bilateral risk for subsequent breast cancer after lobular carcinomain-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 2005; 23:5534-5541
29. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005; 97:1652-1662
30. Tchou J, Hou N, Rademaker A, Jordan VC, Morrow M. Acceptance of tamoxifen chemoprevention by physicians and women at risk. Cancer 2004; 100:1800-1806
31. Cuzick J, Forbes J, Edwards R, et al.; IBIS Investigators. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 2002; 360:817-824
32. Moyer VA. Medications for risk reduction of primary breast cancer in women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2013 [Epub ahead of print]
33. Friedlander LC, Roth SO, Gavenonis SC. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 2011; 261:421-427